Sage Journals: Discover world-class research

Abstract

The National Partnership to Improve Dementia Care in Nursing Homes (i.e., the National Partnership) was launched in March 2012. Using national Medicare, Minimum Data Set, and Nursing Home Compare data in CY 2010–2014, we examined changes in hospital readmissions for older post-acute skilled nursing facility (SNF) residents with Alzheimer’s disease or related dementias (ADRD) following the National Partnership. Using residents without ADRD as reference group to control for concurrent policy and SNF quality changes, we estimated linear probability models to examine the relationship between readmissions and the National Partnership for residents with ADRD, and also stratified the analysis by quality of SNFs. We found a decreasing trend in hospital readmissions over time. The risk of readmissions in residents with ADRD decreased additional 0.3 percentage-point s (p < .01) after the launch of the National Partnership. This relationship varied across SNFs with different quality, as it was stronger in high-quality compared to low-quality SNFs.

Keywords

nursing homes antipsychotics dementia hospital readmission the national partnership to improve dementia care in nursing homes

Get full access to this article

View all access options for this article.

References

Aud

M. A.

(2004). Dangerous wandering: Elopements of older adults with dementia from long-term care facilities. American Journal of Alzheimer's Disease & Other Dementias®, 19(6), 361–368. https://doi.org/10.1177/153331750401900602

Ballard

Orrell

YongZhong

Moniz-Cook

Stafford

Whittaker

Woods

Corbett

Garrod

Woodward-Carlton

Wenborn

Fossey

Khan

(2015). Impact of antipsychotic review and nonpharmacological intervention on antipsychotic use, neuropsychiatric symptoms, and mortality in people with dementia living in nursing homes: A factorial cluster-randomized controlled trial by the well-being and health for people with dementia (WHELD) program. American Journal of Psychiatry, 173(3), 252–262. https://doi.org/10.1176/appi.ajp.2015.15010130

Bowblis

J. R.

Lucas

J. A.

Brunt

C. S.

(2015). The effects of antipsychotic quality reporting on antipsychotic and psychoactive medication use. Health Services Research, 50(4), 1069–1087. https://doi.org/10.1111/1475-6773.12281

CMS (2018a). How hospice works. https://www.medicare.gov/what-medicare-covers/part-a/how-hospice-works.html

CMS (2018b). Readmissions reduction program (HRRP). https://www.cms.gov/medicare/medicare-fee-for-service-payment/acuteinpatientpps/readmissions-reduction-program.html

CMS (2020a). Medicare post-acute care & hospice - by provider and service. https://data.cms.gov/provider-summary-by-type-of-service/medicare-post-acute-care-hospice/medicare-post-acute-care-hospice-by-provider-and-service

CMS (2020b). National partnership - dementia care resources. https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/National-Partnership-Dementia-Care-Resources

CMS (2021). National partnership to improve dementia care in nursing homes: Antipsychotic medication use data report. https://www.cms.gov/files/document/antipsychotic-medication-use-data-report-2020q4-updated-07302021.pdf

Douglas

James

Ballard

(2004). Non-pharmacological interventions in dementia. Advances in Psychiatric Treatment, 10(3), 171–177. https://doi.org/10.1192/apt.10.3.171

10.

FDA (2005). Public health advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances. https://wayback.archive-it.org/7993/20170113112252/http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm053171.htm

11.

FDA (2008). Information for healthcare professionals: Conventional antipsychotics. https://wayback.archive-it.org/7993/20170722190727/https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124830.htm

12.

GAO (2015). Report to congressional requesters: Antipsychotic drug use. https://www.gao.gov/assets/670/668221.pdf

13.

Gill

S. S.

Bronskill

S. E.

Normand

S.-L. T.

Anderson

G. M.

Sykora

Lam

Bell

C. M.

Lee

P. E.

Fischer

H. D.

Gurwitz

J. H.

Rochon

P. A.

Herrmann

(2007). Antipsychotic drug use and mortality in older adults with dementia. Annals of Internal Medicine, 146(11), 775–786. https://doi.org/10.7326/0003-4819-146-11-200706050-00006

14.

Gitlin

L. N.

Kales

H. C.

Lyketsos

C. G.

(2012). Nonpharmacologic management of behavioral symptoms in dementia. Jama, 308(19), 2020–2029. https://doi.org/10.1001/jama.2012.36918

15.

Grabowski

D. C.

Hirth

R. A.

Intrator

Richardson

Stevenson

D. G.

Zheng

Banaszak-Holl

(2016). Low-quality nursing homes were more likely than other nursing homes to be bought or sold by chains in 1993–2010. Health Affairs, 35(5), 907–914. https://doi.org/10.1377/hlthaff.2015.1042

16.

Gurwitz

J. H.

Bonner

Berwick

D. M.

(2017). Reducing excessive use of antipsychotic agents in nursing homes. Jama, 318(2), 118–119. https://doi.org/10.1001/jama.2017.7032

17.

Hersch

E. C.

Falzgraf

(2007). Management of the behavioral and psychological symptoms of dementia. Clinical Interventions in Aging, 2(4), 611–621. https://doi.org/10.2147/cia.s1698

18.

Hughes

C. M.

Lapane

K. L.

Mor

(2000). Influence of facility characteristics on use of antipsychotic medications in nursing homes. Medical Care, 38(12), 1164–1173. https://doi.org/10.1097/00005650-200012000-00003

19.

Johnell

Jonasdottir Bergman

Fastbom

Danielsson

Borg

Salmi

(2017). Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults. International Journal of Geriatric Psychiatry, 32(4), 414–420. https://doi.org/10.1002/gps.4483

20.

Kamble

Chen

Sherer

Aparasu

R. R.

(2008). Antipsychotic drug use among elderly nursing home residents in the United States. The American Journal of Geriatric Pharmacotherapy, 6(4), 187–197. https://doi.org/10.1016/j.amjopharm.2008.10.002

21.

Kate

N. S.

Pawar

S. S.

Parkar

S. R.

Sawant

N. S.

(2015). Adverse drug reactions due to antipsychotics and sedative-hypnotics in the elderly. Journal of Geriatric Mental Health, 2(1), 16. https://doi.org/10.4103/2348-9995.161377

22.

Morris

J. N.

Fries

B. E.

Morris

S. A.

(1999). Scaling ADLs within the MDS. The Journals of Gerontology: Series A, 54(11), M546–M553. https://doi.org/10.1093/gerona/54.11.m546

23.

Ouslander

J. G.

Lamb

Perloe

Givens

J. H.

Kluge

Rutland

Atherly

Saliba

(2010). Potentially avoidable hospitalizations of nursing home residents: Frequency, causes, and costs. Journal of the American Geriatrics Society, 58(4), 627–635. https://doi.org/10.1111/j.1532-5415.2010.02768.x

24.

Ouslander

J. G.

Lamb

Tappen

Herndon

Diaz

Roos

B. A.

Grabowski

D. C.

Bonner

(2011). Interventions to reduce hospitalizations from nursing homes: evaluation of the INTERACT II collaborative quality improvement project. Journal of the American Geriatrics Society, 59(4), 745–753. https://doi.org/10.1111/j.1532-5415.2011.03333.x

25.

Park

Werner

R. M.

(2011). Changes in the relationship between nursing home financial performance and quality of care under public reporting. Health Economics, 20(7), 783–801. https://doi.org/10.1002/hec.1632

26.

Phelan

E. A.

Borson

Grothaus

Balch

Larson

E. B.

(2012). Association of incident dementia with hospitalizations. Jama, 307(2), 165–172. https://doi.org/10.1001/jama.2011.1964

27.

Rochon

P. A.

Normand

S.-L.

Gomes

Gill

S. S.

Anderson

G. M.

Melo

Gurwitz

J. H.

(2008). Antipsychotic therapy and short-term serious events in older adults with dementia. Archives of Internal Medicine, 168(10), 1090–1096. https://doi.org/10.1001/archinte.168.10.1090

28.

Sink

K. M.

Covinsky

K. E.

Newcomer

Yaffe

(2004). Ethnic differences in the prevalence and pattern of dementia‐related behaviors. Journal of the American Geriatrics Society, 52(8), 1277–1283. https://doi.org/10.1111/j.1532-5415.2004.52356.x

29.

Spilsbury

Hewitt

Stirk

Bowman

(2011). The relationship between nurse staffing and quality of care in nursing homes: A systematic review. International Journal of Nursing Studies, 48(6), 732–750. https://doi.org/10.1016/j.ijnurstu.2011.02.014

30.

Thomas

K. S.

Dosa

Wysocki

Mor

(2017). The minimum data set 3.0 cognitive function scale. Medical Care, 55(9), e68–e72. https://doi.org/10.1097/mlr.0000000000000334

31.

Wang

Temkin-Greener

Conwell

Cai

(2020). Policy to reduce antipsychotic use and hospitalization of nursing home residents with dementia. Journal of the American Medical Directors Association, 21(11), 1617–1622. e1613.

32.

Wooldridge

J. M.

(2010). Econometric analysis of cross section and panel data. MIT press.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.65 MB

The National Partnership to Improve Dementia Care and Hospital Readmission Among Skilled Nursing Facility Residents

Abstract

Keywords

Get full access to this article

References

Supplementary Material